Regenics offers prescribed compounded NAD+ injections with medication, supplies, and instructions shipped to the patient. Its product page is unusually explicit that much of the research involves oral precursors or animal models rather than the compounded injectable preparation being sold. That is a useful distinction for prospective customers.
We reviewed the current injection page on September 19, 2026. We did not purchase the product. Alongside the evidence caveat, we found quantity and injection-count descriptions that do not line up clearly, making a prescription-specific explanation important before using the page to estimate cost or supply duration.
Regenics gives useful evidence caveats, but its quantity descriptions need reconciliation. Get the actual label, supplied amount, price, and schedule from the care team.
What the home-delivery offer describes
The Regenics product page describes a medication package with supplies, instructions, provider support, and shipment from a U.S. pharmacy partner. It identifies intramuscular and subcutaneous use in the product description. The route for an individual patient still needs to come from the prescription and pharmacy label.
Ask whether you are being quoted for the shipped injection service or a separate in-person treatment. Regenics also has clinic-related services, and those experiences should not be assumed to share the same price or logistics. Our near-me versus online guide explains the differences to resolve before making a comparison.
The listed quantities need a written explanation
The page presents total ingredient amounts, a stated amount per injection, and injection counts that are not internally consistent. Its selector also includes several potency options. We do not convert that sales copy into a dosing plan or an estimate of how many usable doses a customer will receive.
Ask the care team to identify the exact preparation, concentration, vial volume, total supplied amount, and prescription instructions in one clear document. The label and dosing questions guide explains why those are separate pieces of information. If they do not agree, have the clinician and pharmacist resolve the discrepancy before use.
The evidence caveat is worth reading
Regenics acknowledges that the existing research may not directly apply to the compounded injectable form and that human evidence for specific clinical outcomes is limited. That is more useful than treating every NAD-related study as proof of the product’s benefits. It also places a necessary boundary around the page’s broader wellness language.
Our evidence review follows the same distinction between a molecule’s biological role and a finished medicine’s demonstrated effects. Ask your clinician which research informs the proposed use and how you would evaluate progress. Testimonials about energy or recovery do not resolve those product-specific questions.
Define the support you would need at home
Regenics advertises ongoing provider support, but you should still ask how clinical questions are handled and what response time is typical. If you need help with equipment or have trouble reading a label, confirm whether a live explanation is available. Instructions should match the product actually shipped, especially when several catalog options exist.
Ask the pharmacy about storage, the labeled usable period, and the process for reporting a damaged or delayed parcel. Also clarify how the service handles a clinician-directed change after a refill has started processing. These practical details can matter more than delivery-speed language when deciding whether an at-home service is a comfortable fit.
Compare Regenics on the details that are confirmed
For other pharmacy-specific online offers, read the Defy Medical review and Lavender Sky Health review. Each highlights different catalog and pricing questions. For a clearer published monthly figure, compare Pomegranate Health while checking the supplied quantity and included care.
The CoreAge Rx review covers our featured commercial partner. Regenics’ acknowledgment of research limits is helpful, but it does not solve the quantity ambiguity or establish an all-in price. A clear written prescription and quote should come before any conclusion about value.
Follow the source
References & further reading
- Regenics — compounded NAD+ injection
Checked September 19, 2026. Quantity and injection-count descriptions need reconciliation. Related-product prices are not treated as NAD+ prices.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.